相关实验视频

Updated: Jul 17, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

在灌注布里莫尼丁滴剂后,用克拉图5M测量眼病患者的客观眼红的改善

Elena Montolío-Marzo¹, Rodrigo Fernández-Narros¹, Laura Morales-Fernández¹

¹Ophthalmology Unit, Department of Ophthalmology and ORL, Faculty of Medicine, Hospital Clínico San-Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San-Carlos (IdISSC), Madrid, Spain.

European journal of ophthalmology

|September 4, 2023

概括

布里莫尼丁在接受局部低血压治疗的玻璃眼患者中显著降低了眼睛的红色. 这一客观发现突出了布里莫尼丁的存在.

科学领域:

眼科医生眼科眼科
玻璃眼研究研究玻璃眼研究
眼科治疗学眼科治疗学

背景情况:

青光眼患者经常经历由于局部低血压治疗而引起的眼睛红色.
对眼睛红的客观测量对于评估治疗疗效和患者舒适度至关重要.
布里莫尼丁是一种已知的血管收缩剂,有可能减少眼睛高血压.

研究的目的:

客观地量化0.2%的布里莫尼丁灌注对玻璃眼患者眼睛红的作用.
通过使用OCULUS Keratograph 5M.比较插入前后的红点得分.
为了评估布里莫尼丁对结膜性高血症的影响的持续时间.

主要方法:

分析了60名接受局部低血压治疗的玻璃眼或眼睛高血压患者的60只眼睛.
在布里莫尼丁灌注前和后使用OCULUS Keratograph 5M红度得分 (RS) 测量眼睛红度.
关键的结果变量包括整体,气囊和肢体红点,膜破裂时间和meibography.

主要成果:

布里莫尼丁灌注导致所有测量的眼睛红度得分显著降低 (p < 0.001).
在30分钟后,平均整体红色得分减少为47.97%,在灌入后1小时后为45.92%.
在防腐剂和无防腐剂治疗之间,以及在组合和单一治疗之间,降低高血压是可比的.

结论:

客观证据证实,在青光眼患者中,布里莫尼丁可显著降低结膜性高血症.
布里莫尼丁在减少眼睛红色方面表现出快速和持续的效果.
这些发现表明,布里莫尼丁可以作为一种手术前措施,用于缓解在绿眼瘤手术中的手术内出血.

关键词:

压力下降的滴滴下降.在OCULUS Keratograph 5M中使用.布里莫尼尼丁.眼睛发红的情况.

更多相关视频

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...